[TVTX] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
04-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -176.90%
YoY- -135.15%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 44,373 40,706 40,340 33,945 28,005 8,349 0 -
PBT -37,013 -54,101 -19,017 -30,646 144,339 -19,556 -10,898 22.59%
Tax -523 415 -1,223 6,467 38,761 -6,529 5,743 -
NP -36,490 -54,516 -17,794 -37,113 105,578 -19,556 -10,898 22.30%
Tax Rate - - - - -26.85% - - -
Total Cost 80,863 95,222 58,134 71,058 -77,573 27,905 10,898 39.63%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -82.23 -133.93 -44.11 -109.33 377.00 -234.25 0.00 -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -0.85 -1.34 -0.46 -1.00 2.95 -0.73 -0.71 3.04%
EPS Diluted -0.85 -1.34 -0.46 -1.00 1.78 -0.69 -0.71 3.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.